Evidence map›Paper›PMID 42180701›Full record

ArticleFrontiers in medicine2026

Translation, cross-cultural adaptation and validation of the Chinese version of irritable bowel syndrome severity scoring system.

Qian Li, Jia-Hao Mo, Hui-Qi Chen, Meng-Xin Chen, Xiao-Jia Ni, Ze-Hui He, Bing-Xiong Ou, Xiu-Cai Fang, Xiao-Bo Yang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qian LiState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Jia-Hao MoThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Hui-Qi ChenState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Meng-Xin ChenThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Xiao-Jia NiThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Ze-Hui HeBig Data Research Center of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Bing-Xiong OuDepartment of Pharmacy, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Xiu-Cai FangDepartement of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xiao-Bo YangState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Given that the Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) is widely utilized in IBS-related clinical research but lacks an officially approved Chinese version (IBS-SSS-C), which has impeded its application in Chinese research contexts. This study aims to translate and cross-culturally adapt the IBS-SSS into a Chinese version, and validate its key properties, thereby developing a reliable and officially recognized tool for assessing IBS severity among the Chinese population. Methods: We obtained translation permission for the IBS-SSS from the Rome Foundation, and translated and cross-culturally adapted it into a Chinese version according to the official guideline. Validation was performed as clinical trials assessing responsiveness to change ( Results: Through forward and backward translation, and cross-cultural adaption, the IBS-SSS-C was developed and approved for use by the Rome Foundation. A significance difference in the absolute change of the IBS-SSS-C total score before and after treatment was found in the AR responder and non-responder groups ( Conclusion: Our findings indicate that the IBS-SSS-C appears to be a reliable and appropriate instrument for IBS outcome assessment in the Chinese population; nevertheless, further validation in larger-scale, multi-center studies is required.

Indexed as

Chinese versionirritable bowel syndromeirritable bowel syndrome severity scoring systemtranslation and cultural adaptationvalidation

Identifiers

PMID42180701
PMCPMC13190209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.